SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001144204-16-108787
Filing Date
2016-06-17
Accepted
2016-06-17 17:16:36
Documents
3
Period of Report
2016-06-16
Filing Date Changed
2016-06-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v442424_8k.htm 8-K 20786
2 EXHIBIT 99.1 v442424_ex99-1.htm EX-99.1 66566
3 GRAPHIC image_001.jpg GRAPHIC 6777
  Complete submission text file 0001144204-16-108787.txt   97953
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 161720885
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1